Literature DB >> 457846

Estradiol formation from testosterone by continuously cultured human breast cancer cells.

J H MacIndoe.   

Abstract

Two human breast cancer cell lines (MCF-7 and MDA-MB-231) and one cell line derived from normal human breast (HBL-100) were examined for the presence of aromatase activity by determining the amounts of [3H]estradiol ([3H]E2) formed by cell cultures incubated with [3H]testosterone. Aromatase activity was demonstrable in both breast cancer cell lines, but estradiol synthesis was not observed in HBL-100 cultures. The [3H]E2 content of MCF-7 cultures rose as a function of incubation time and substrate concentration. Furthermore, [3H]E2 formation by this cell line was suppressed by several known inhibitors of human placental aromatase. These observations represent the first evidence that some lines of continuously cultured human breast cancer cells, like some human breast tumors, are capable of forming estrogen from an extracellular precursor steroid. Cultured breast cells may provide model systems for investigating the relative importance of intracellular estrogen formation in the regulation of human breast cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457846     DOI: 10.1210/jcem-49-2-272

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminoglutethimide.

Authors:  Y de Launoit; R Kiss
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 2.  Recent advances in studies on estrogen biosynthesis.

Authors:  A M Brodie
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

3.  Growth inhibitors in plasma derived human serum.

Authors:  D A Pigott; M A Grimaldi; M L Dell'Aquila; E V Gaffney
Journal:  In Vitro       Date:  1982-07

4.  Androgen metabolism and apocrine differentiation in human breast cancer.

Authors:  W R Miller; J Telford; J M Dixon; A A Shivas
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  New cell lines of human breast cancer origin.

Authors:  G Calaf; J Abarca-Quinones; F Feuilhade; J Beaune; G Dupre; M Orrico; N Barnabas-Sohi; J C Kouyoumdjian
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.

Authors:  Todd W Miller; Marianela Pérez-Torres; Archana Narasanna; Marta Guix; Olle Stål; Gizeh Pérez-Tenorio; Ana M Gonzalez-Angulo; Bryan T Hennessy; Gordon B Mills; J Phillip Kennedy; Craig W Lindsley; Carlos L Arteaga
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

7.  Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells.

Authors:  J H MacIndoe; M Hinkhouse; G Woods
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

8.  A cell line (HBL-100) established from human breast milk.

Authors:  E V Gaffney
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

9.  Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines.

Authors:  A E Lykkesfeldt; P Briand
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

10.  Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells.

Authors:  V M Macaulay; J E Nicholls; J Gledhill; M G Rowlands; M Dowsett; A Ashworth
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.